MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.

[1]  R. Roncucci,et al.  Effects of mlacemide on glutamate decarboxylase activity in rat striatum syraaptosomal fractions , 1990 .

[2]  R. Miller,et al.  Ifenprodil is a novel type of N-methyl-D-aspartate receptor antagonist: interaction with polyamines. , 1989, Molecular pharmacology.

[3]  J. Mey,et al.  The Novel Neuropsychotropic Agent Milacemide Is a Specific Enzyme‐Activated Inhibitor of Brain Monoamine Oxidase B , 1989, Journal of neurochemistry.

[4]  N. Satoh,et al.  Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[5]  S. Fahn,et al.  Monoamine oxidase inhibitory properties of milacemide in rats. , 1989, Life sciences.

[6]  D. Kerem,et al.  The glycine-prodrug, milacemide, increases the seizure threshold due to hyperbaric oxygen; prevention by 1-deprenyl. , 1988, European journal of pharmacology.

[7]  M. Youdim,et al.  Formation of the Neurotransmitter Glycine from the Anticonvulsant Milacemide Is Mediated by Brain Monoamine Oxidase B , 1988, Journal of neurochemistry.

[8]  R. Roncucci,et al.  Effect of milacemide (M) on the levels of dopamine, serotonin and their metabolites in rat substantia nigra and striatum , 1988 .

[9]  A. Cordi,et al.  Anticonvulsant activity of milacemide. , 1983, Archives internationales de pharmacodynamie et de therapie.

[10]  J. Korf,et al.  Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system. , 1983, Biochemical pharmacology.

[11]  L. Gillet,et al.  Conversion of orally administered 2-n.pentylaminoacetamide into glycinamide and glycine in the rat brain. , 1983, Life sciences.

[12]  W. Löscher,et al.  Di-n-propylacetic acid--profile of anticonvulsant activity in mice. , 1976, Arzneimittel-Forschung.